3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Longitudinal Auxological recovery in a cohort of children with Hyperinsulinaemic Hypoglycaemia

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Hypoglycaemia due to hyperinsulinism (HI) is the commonest cause of severe, recurrent hypoglycaemia in childhood. Cohort outcomes of HI remain to be described and whilst previous follow up studies have focused on neurodevelopmental outcomes, there is no information available on feeding and auxology.

          Aim

          We aimed to describe HI outcomes for auxology, medications, feeding and neurodevelopmental in a cohort up to age 5 years.

          Method

          We reviewed medical records for all patients with confirmed HI over a three-year period in a single centre to derive a longitudinal dataset.

          Results

          Seventy patients were recruited to the study. Mean weight at birth was − 1.0 standard deviation scores (SDS) for age and sex, while mean height at 3 months was − 1.5 SDS. Both weight and height trended to the population median over the follow up period. Feeding difficulties were noted in 17% of patients at 3 months and this reduced to 3% by 5 years. At age 5 years, 11 patients (15%) had neurodevelopmental delay and of these only one was severe. Resolution of disease was predicted by lower maximum early diazoxide dose ( p = 0.007) and being born SGA ( p = 0.009).

          Conclusion

          In a three-year cohort of HI patients followed up for 5 years, in spite of feeding difficulties and carbohydrate loading in early life, auxology parameters are normal in follow up. A lower than expected rate of neurodevelopmental delay could be attributed to prompt early treatment.

          Related collections

          Most cited references17

          • Record: found
          • Abstract: found
          • Article: not found

          Perspective on the Genetics and Diagnosis of Congenital Hyperinsulinism Disorders.

          Congenital hyperinsulinism (HI) is the most common cause of hypoglycemia in children. The risk of permanent brain injury in infants with HI continues to be as high as 25-50% due to delays in diagnosis and inadequate treatment. Congenital HI has been described since the birth of the JCEM under various terms, including "idiopathic hypoglycemia of infancy," "leucine-sensitive hypoglycemia," or "nesidioblastosis."
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Long-term follow-up of 114 patients with congenital hyperinsulinism.

            The term congenital hyperinsulinism (CHI) comprises a group of different genetic disorders with the common finding of recurrent episodes of hyperinsulinemic hypoglycemia. To evaluate the clinical presentation, diagnostic criteria, treatment and long-term follow-up in a large cohort of CHI patients. The data from 114 patients from different hospitals were obtained by a detailed questionnaire. Patients presented neonatally (65%), during infancy (28%) or during childhood (7%). In 20 of 74 (27%) patients with neonatal onset birth weight was greatly increased (group with standard deviation scores (SDS) >2.0) with a mean SDS of 3.2. Twenty-nine percent of neonatal-onset vs 69% of infancy/childhood-onset patients responded to diazoxide and diet or to a carbohydrate-enriched diet alone. Therefore, we observed a high rate of pancreatic surgery performed in the neonatal-onset group (70%) compared with the infancy/childhood-onset group (28%). Partial (3%), subtotal (37%) or near total (15%) pancreatectomy was performed. After pancreatic surgery there appeared a high risk of persistent hypoglycemia (40%). Immediately post-surgery or with a latency of several Years insulin-dependent diabetes mellitus was observed in operated patients (27%). General outcome was poor with a high degree of psychomotor or mental retardation (44%) or epilepsy (25%). An unfavorable outcome correlated with infancy-onset manifestation (chi(2)=6.1, P=0.01). The high degree of developmental delay, in particular in infancy-onset patients emphasizes the need for a change in treatment strategies to improve the unfavorable outcome. Evaluation of treatment alternatives should take the high risk of developing diabetes mellitus into account.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Therapies and outcomes of congenital hyperinsulinism‐induced hypoglycaemia

              Abstract Congenital hyperinsulinism is a rare disease, but is the most frequent cause of persistent and severe hypoglycaemia in early childhood. Hypoglycaemia caused by excessive and dysregulated insulin secretion (hyperinsulinism) from disordered pancreatic β cells can often lead to irreversible brain damage with lifelong neurodisability. Although congenital hyperinsulinism has a genetic cause in a significant proportion (40%) of children, often being the result of mutations in the genes encoding the KATP channel ( ABCC8 and KCNJ11), not all children have severe and persistent forms of the disease. In approximately half of those without a genetic mutation, hyperinsulinism may resolve, although timescales are unpredictable. From a histopathology perspective, congenital hyperinsulinism is broadly grouped into diffuse and focal forms, with surgical lesionectomy being the preferred choice of treatment in the latter. In contrast, in diffuse congenital hyperinsulinism, medical treatment is the best option if conservative management is safe and effective. In such cases, children receiving treatment with drugs, such as diazoxide and octreotide, should be monitored for side effects and for signs of reduction in disease severity. If hypoglycaemia is not safely managed by medical therapy, subtotal pancreatectomy may be required; however, persistent hypoglycaemia may continue after surgery and diabetes is an inevitable consequence in later life. It is important to recognize the negative cognitive impact of early‐life hypoglycaemia which affects half of all children with congenital hyperinsulinism. Treatment options should be individualized to the child/young person with congenital hyperinsulinism, with full discussion regarding efficacy, side effects, outcomes and later life impact.
                Bookmark

                Author and article information

                Contributors
                chrisworth88@doctors.org.uk
                Journal
                Orphanet J Rare Dis
                Orphanet J Rare Dis
                Orphanet Journal of Rare Diseases
                BioMed Central (London )
                1750-1172
                24 June 2020
                24 June 2020
                2020
                : 15
                : 162
                Affiliations
                [1 ]GRID grid.415910.8, ISNI 0000 0001 0235 2382, Department of Paediatric Endocrinology, , Royal Manchester Children’s Hospital, ; Oxford Road, Manchester, M13 9WL UK
                [2 ]Department of Paediatrics, Nizwa Hospital, Nizwa, Sultanate of Oman
                [3 ]Department of Pediatrics, Division of Endocrinology, Jim Pattison Children’s Hospital, Saskatoon, Canada
                [4 ]GRID grid.5379.8, ISNI 0000000121662407, Dept of Mathematics, , University of Manchester, ; Manchester, UK
                [5 ]GRID grid.8391.3, ISNI 0000 0004 1936 8024, Institute of Biomedical and Clinical Science, , University of Exeter Medical School, ; Exeter, UK
                [6 ]GRID grid.5379.8, ISNI 0000000121662407, Faculty of Biology, Medicine and Health, , University of Manchester, ; Manchester, UK
                Author information
                http://orcid.org/0000-0001-6609-2735
                Article
                1438
                10.1186/s13023-020-01438-0
                7313198
                97affb27-fe81-40cb-b57c-16310ed3ab36
                © The Author(s) 2020

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 16 March 2020
                : 15 June 2020
                Funding
                Funded by: Manchester Academic Health Science Centre
                Funded by: Northern Congenital Hyperinsulinism Charitable Fund
                Funded by: The University of Manchester MRC Confidence in Concept (CiC) Award
                Award ID: MC_PC_18056
                Award Recipient :
                Funded by: Research Councils UK Academic Fellowship
                Funded by: Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society
                Award ID: 105636/Z/14/Z
                Award Recipient :
                Categories
                Research
                Custom metadata
                © The Author(s) 2020

                Infectious disease & Microbiology
                congenital hyperinsulinism,natural history,height,weight,diazoxide,outcomes,hypoglycaemia,neurodevelopment

                Comments

                Comment on this article